Table 3.
Study | HR | 95% CI (LL–UL) | P-value | Outcome | Origin | Expression |
---|---|---|---|---|---|---|
Bovell et al,27 2013 | 1.9 | 1.05–3.43 | 0.002 | OS | Tissue | Upregulated |
Croce et al,30 2013 | 3.2 | 1.1–9.4 | 0.03 | OS | Tissue | Upregulated |
Deng et al,25 2016 | 0.62 | 0.32–1.2 | 0.0006 | OS | Tissue | Downregulated |
Deng et al,25 2016 | 0.36 | 0.20–0.64 | 0.0001 | OS | Serum | Downregulated |
Hur et al,8 2017 | 1.56 | 0.80–3.05 | 0.1962 | OS | Tissue | Upregulated |
Hur et al,8 2017 | 4.47 | 2.10–9.5 | 0.0001 | OS | Serum | Upregulated |
Schetter et al,28 2008 | 3.1 | 1.5–6.4 | 0.003 | OS | Tissue | Upregulated |
Tao et al,26 2014 | 1.38 | 0.77–2.47 | 0.273 | OS | Tissue | Upregulated |
Toiyama et al,29 2012 | 2.6 | 1.17–5.77 | 0.019 | OS | Serum | Upregulated |
Abbreviations: CI, confidence interval; HR, hazard ratio; LL, lower limit; OS, overall survival; UL, upper limit.